Canada has the potential to revolutionize its approach to rare genetic diseases, but it requires a paradigm shift in how it manages and shares data. The country's current landscape is a patchwork of innovative programs and infrastructure, yet these initiatives often suffer from short-term funding, limited budgets, and a lack of coordination, leading to duplication of efforts and reinventing the wheel. This fragmentation presents an opportunity for Canada to create a more integrated, equitable, and efficient system for those living with rare diseases. The key to unlocking this potential lies in embracing data sharing and establishing a robust, national infrastructure for a learning health ecosystem.
One of the critical challenges in diagnosing rare genetic diseases is the interpretation of DNA variants. Knowing someone's DNA sequence is only the beginning; it is the comparison of this data to large-scale datasets that provides a diagnosis. This process relies on data sharing, which is essential for accessing information on variant frequency, functional effect, familial inheritance, and clinical presentation. In Canada, the All for One Data Sharing Agreement has created a framework for responsible data sharing, enabling the exchange of clinically generated genomic and health data between diagnostic laboratories. This is further supported by the Canadian Open Genetics Repository and the Silent Genome's Indigenous Background Variant Library, which aid in the interpretation of genetic tests.
However, the current situation is not without its challenges. Many of these initiatives are supported through short-term funding cycles and limited budgets, making it difficult to sustain, scale, or integrate successful programs over the long term. Additionally, funding structures often prioritize new initiatives over the expansion and coordination of existing ones, contributing to duplication of effort and a tendency to reinvent the wheel. This fragmentation is a missed opportunity for Canada to create a more integrated, equitable, and efficient system for those living with rare diseases.
To address these challenges, Canada needs to embrace a federated approach to data sharing. This approach allows data to remain within trusted institutions and jurisdictions while becoming discoverable, comparable, and usable through shared standards, governance, and infrastructure. This aligns with Canada's Expert Advisory Group on the Pan-Canadian Health Data Strategy, which calls for stronger health data foundations, including federated governance, interoperability, supportive policy, and public engagement. By adopting this approach, Canada can create a more integrated, equitable, and efficient system for those living with rare diseases.
To make responsible data sharing routine rather than exceptional, Canada needs four shifts. First, the country needs federal leadership for genomic data sharing. Because healthcare is administered provincially and territorially, data sharing will remain uneven without top-down mandates or strong national coordination, clear expectations, and sustained investment. Canada needs to follow in the footsteps of countries like England, Australia, and Denmark, which have created national strategies or government bodies for genomic medicine and health data infrastructure, backed by hundreds of millions of dollars over long-term, decade-scale timelines. Second, data sharing must be recognized and funded as core diagnostic infrastructure, not an optional add-on. When genomic testing is funded, the costs of responsible data sharing, interoperability, and legal/data governance support should be built into the model. Third, Canada must establish national standards for RD testing and data. This includes clear, pan-Canadian requirements for publicly funded genomic testing, including eligibility criteria, laboratory accreditation, and professional certification. Finally, patients, families, and communities must be partners in governance. Many RD communities have long advocated for their data to be used to accelerate diagnosis, research, and care. Trust is built not by avoiding data sharing, but by ensuring that sharing is purposeful, transparent, secure, reciprocal, and aligned with patient and community priorities.
In conclusion, Canada has the potential to revolutionize its approach to rare genetic diseases, but it requires a paradigm shift in how it manages and shares data. By embracing data sharing and establishing a robust, national infrastructure for a learning health ecosystem, Canada can create a more integrated, equitable, and efficient system for those living with rare diseases. Every test, every unsolved case, every diagnosis, and every patient experience can help strengthen the system for the next person. But this will only happen if data sharing is treated as core health infrastructure, supported by sustained investment, policy alignment, and coordination across jurisdictions and sectors.
